Dextromethorphan (DXM) & MDMA
Dextromethorphan (DXM) is a widely used over-the-counter cough suppressant that has dissociative and hallucinogenic properties when taken at higher doses. It works primarily by acting as an NMDA (N-methyl-D-aspartate) receptor antagonist, which is the same mechanism of action as substances like ketamine and PCP. By binding to NMDA receptors in the brain, DXM inhibits the action of glutamate, a major excitatory neurotransmitter. Glutamate is involved in many cognitive functions, including learning, memory, and sensory perception. When the NMDA receptors are blocked by DXM, there is a reduction in glutamatergic signaling, leading to dissociative effects, altered sensory perceptions, and a sense of detachment from reality, which are typical of dissociative drugs.
In addition to its NMDA receptor antagonism, DXM also affects other neurotransmitter systems. One of its secondary actions is on serotonin, which is why it can cause a range of mood-related effects, including euphoria, anxiety, and sometimes even hallucinations at higher doses. The drug is known to inhibit the reuptake of serotonin, leading to increased serotonin levels in the synaptic cleft, which can also increase the risk of serotonin syndrome if combined with other serotonergic drugs.
At lower doses, DXM acts as a cough suppressant with minimal effects on the central nervous system, primarily by acting on the brain's cough center in the medulla. However, when taken in large amounts, DXM can produce altered states of consciousness, ranging from mild euphoria and relaxation to intense dissociation and hallucinations. These effects are dose-dependent, with higher doses leading to stronger dissociative and hallucinogenic experiences.
DXM also has some affinity for opioid receptors, particularly the sigma-1 receptor, but it is not considered a typical opioid. At high doses, this interaction with sigma receptors can contribute to some of the drug's mood-altering and dissociative effects. However, unlike traditional opioids, DXM does not cause significant respiratory depression, which makes it somewhat less dangerous in terms of overdose, although it can still be harmful when abused.
MDMA (3,4-methylenedioxymethamphetamine), commonly known as ecstasy or molly, is a synthetic drug that affects the brain by increasing the activity of several neurotransmitters, particularly serotonin, dopamine, and norepinephrine. Its primary action occurs at the level of serotonin, where it causes a massive release of serotonin from nerve terminals into the synapse (the space between nerve cells), leading to an increase in serotonin levels in the brain. This release is responsible for many of the characteristic effects of MDMA, including feelings of emotional warmth, empathy, emotional openness, and enhanced sensory perception. These effects make it popular in recreational settings, especially in social and music-related environments.
In addition to serotonin, MDMA also affects dopamine and norepinephrine systems. The release of dopamine is associated with the euphoric and rewarding feelings that users experience, similar to other stimulants like cocaine or amphetamines. Dopamine release contributes to the feelings of pleasure and excitement, while norepinephrine, which is involved in the body’s "fight or flight" response, increases heart rate and blood pressure, leading to the stimulating effects of the drug. The combined increase in serotonin, dopamine, and norepinephrine leads to MDMA’s complex profile of stimulant and empathogenic effects.
The way MDMA works on serotonin is particularly notable. In addition to promoting the release of serotonin, MDMA also inhibits the reuptake of serotonin, meaning it blocks the transporter responsible for taking serotonin back into the nerve cells after it has been released. This further amplifies the serotonin signal in the brain, prolonging the effects of the drug. However, after the drug is metabolized and its effects wear off, there can be a "serotonin depletion," which can lead to negative aftereffects such as feelings of depression, irritability, and anxiety. This is partly due to the fact that MDMA causes a significant amount of serotonin to be released all at once, leaving less serotonin available in the brain for a period after the drug’s effects subside.
In addition to its direct effects on neurotransmitters, MDMA also has indirect effects on other systems in the body. For example, the increase in norepinephrine can lead to vasoconstriction (narrowing of blood vessels), which can raise blood pressure.
The combination of DXM and MDMA could lead to a range of unpredictable and potentially dangerous effects due to the way each drug interacts with neurotransmitter systems in the brain, especially serotonin.
DXM, while primarily an NMDA receptor antagonist, also increases serotonin levels. This shared serotonergic activity means that when both drugs are taken together, there is a risk of overwhelming the serotonin system, leading to serotonin syndrome. Symptoms of this condition can include agitation, confusion, fever, tachycardia, hyperreflexia, muscle rigidity, and, in severe cases, seizures or death.
In addition to the risk of serotonin syndrome, combining DXM and MDMA could lead to intensified dissociative effects. DXM, particularly at higher doses, produces dissociative and hallucinogenic effects. MDMA also alters perception, though typically in a more empathogenic and stimulant-driven way. When combined, these effects could be magnified, potentially leading to an overwhelming or uncomfortable experience, including confusion, agitation, or psychosis, particularly in sensitive individuals or those taking higher doses.
Both drugs also have stimulating effects on the body, with MDMA increasing heart rate and blood pressure due to its release of norepinephrine. DXM, while not a stimulant in the traditional sense, can still have cardiovascular effects, especially when taken in high doses. Together, these drugs may put undue stress on the cardiovascular system, increasing the risk of arrhythmias, heart attacks, or strokes, particularly in individuals with pre-existing heart conditions.
Moreover, DXM can lower the seizure threshold, which, when combined with the stimulating effects of MDMA, may increase the risk of seizures, particularly at higher doses or in combination with other substances. This can be further complicated by the dehydrating effects of MDMA, as users often engage in prolonged physical activity, such as dancing, in hot environments, increasing the risk of overheating (hyperthermia) and dehydration, which can have dangerous consequences when compounded by the other effects of DXM and MDMA.
Cognitively, combining these drugs could impair judgment, concentration, and memory, and the person may struggle with reality, experiencing severe confusion or even delusions, as both substances affect perception and thought processes in different ways. The dissociative effects of DXM could obscure the typical euphoric or empathogenic effects of MDMA, leading to a mismatch between the physical stimulation of MDMA and the dissociative, sometimes numbing effects of DXM, creating a disorienting experience.
All things considered, we recommend avoiding this combination.
Last edited by a moderator: